ResMed (RMD) Rose 15% in Q3
Fidelity Investments, an investment management company, recently released its “Fidelity Growth Strategies Fund” third quarter 2024 investor letter. A copy of the letter can be downloaded here.
Resmed Inc (RMD)
Market is closed
News
- 1 - 10
- Next >>
ResMed Inc. (NYSE:RMD) Q1 2025 Earnings Call Transcript
Operator: Hello, and welcome to the Q1 Fiscal Year 2025 ResMed Earnings Conference Call. My name is Kevin, and I'll be your operator for today's call.
ResMed Inc. (NYSE:RMD) Q4 2024 Earnings Call Transcript
Operator: Hello, and welcome to the Q4 Fiscal Year 2024 ResMed Earnings Conference Call. My name is Kevin, and I'll be your operator for today's call.
ResMed Inc. (NYSE:RMD) Q3 2024 Earnings Call Transcript
ResMed Inc. beats earnings expectations. Reported EPS is $2.13, expectations were $1.91. ResMed Inc.
20 Fastest Growing Health Tech Companies in the World
In this article, we will be taking a look at the 20 fastest growing health tech companies in the world.
25 Most Valuable Medical Device Companies in the US
In this article, we will be taking a look at the 25 most valuable medical device companies in the US.
ResMed Inc. (NYSE:RMD) Q2 2024 Earnings Call Transcript
Operator: Hello, and welcome to the ResMed Second Quarter Fiscal Year 2024 Earnings Conference Call and Webcast.
ResMed Inc. (NYSE:RMD) Q1 2024 Earnings Call Transcript
Operator: Hello, and welcome to the ResMed First Quarter Fiscal Year 2024 Earnings Conference Call and Webcast [Operator Instructions]. As a reminder, this conference is being recorded.
5 Oversold Healthcare Stocks to Buy
Root, Switzerland-based NovoCure Limited (NASDAQ:NVCR) is a global oncology company working to extend survival in some of the most aggressive forms of cancer through the development and commercialization...
5 Oversold Growth Stocks To Buy
In this piece, we will take a look at the five oversold growth stocks to buy.
- 1 - 10
- Next >>
Billionaire Hedge Funds
